Skip to main navigation Skip to search Skip to main content

Kaposi's sarcoma in an HIV-negative CLL patient as the cause of thrombocytopenia

  • P. W. Wijermans*
  • , K. van Groningen
  • , E. A. van Royen
  • , J. A. Bruijn
  • *Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

A patient is described with a rapidly progressive Kaposi's sarcoma following immunosuppressive therapy with fludarabine monophosphate (FAMP) for chronic lymphocytic leukemia. The development of this tumor was accompanied by progressive thrombocytopenia, due to trapping of the platelets in the Kaposi sarcoma, without signs of consumptive coagulopathy or microangiopathic hemolytic anemia. This sequestration process might be caused by the abnormal structure of the tumoral vessels, leading to exposure of subendothelial structures like collagen, von Willebrand's factor, and tenascin to the vessel lumen. A severe immunosuppression due to the lymphocytotoxic effect of FAMP on several T-cell subpopulations was seen. This case confirms the importance of immunosuppression as a cofactor in the development of Kaposi's sarcoma also in HIV-negative patients, and adds Kaposi's sarcoma to the differential diagnosis of thrombocytopenia in immunosuppressed patients. © 1994 Springer-Verlag.
Original languageEnglish
Pages (from-to)307-310
JournalAnnals of hematology
Volume68
Issue number6
DOIs
Publication statusPublished - Jun 1994
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Kaposi's sarcoma in an HIV-negative CLL patient as the cause of thrombocytopenia'. Together they form a unique fingerprint.

Cite this